Hylartin V

Hylartin V

Hylartin V Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Do not use in horses intended for human consumption.

HYLARTIN® V must not be administered intravascularly.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


There is currently no usage information available for this product. We apologize for any inconvenience.


There is currently no drug history available for this drug.

Other Information

HYLARTIN® V is a sterile pyrogen-free solution of a highly purified, specific fraction of the sodium salt of hyaluronic acid extracted from rooster combs. HYLARTIN® V is supplied in disposable glass syringes, each of which contains 20 mg (10 mg/mL) of sodium hyaluronate in 2.0 mL physiological sodium chloride-phosphate buffer with a pH of 7.0–7.5.

Hylartin V Manufacturers

  • Pharmacia & Upjohn Company
    Hylartin V (Hyaluronate Sodium) Injection [Pharmacia & Upjohn Company]
  • Zoetis Inc.
    Hylartin V (Hyaluronate Sodium) Injection [Zoetis Inc.]

Login To Your Free Account